Genasense (oblimersen sodium)

By Business Review Editor

Pharma Deals Review: Vol 2007 Issue 88 (Table of Contents)

Published: 7 Oct-2007

DOI: 10.3833/pdr.v2007.i88.273     ISSN: 1756-7874

Section: Deal Trackers



Genasense® (oblimersen sodium) is an antisense oligonucleotide (ASO) developed by Genta for systemic use as an injection. It comprises a phosphorothioate backbone linking 18 modifi ed DNA bases, and targets the fi rst six codons of BCL-2 mRNA to form a DNA/RNA complex, which is subsequently recognised as foreign and cleaved enzymatically...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details